Clinical Trials
14 trialsNCT05027425 2026-05-06
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Phase 2 Terminated
NCT02968810 2026-05-04
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT03534141 2025-05-16
MHALT
University of California, San Francisco
Phase NA Terminated
NCT04482855 2024-11-19
Low-Level Laser in Head and Neck Chronic Lymphedema
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT03030859 2024-04-11
Self-Care for Head and Neck Cancer Survivors With Lymphedema and Fibrosis
University of Pennsylvania
Phase NA Completed
NCT02273362 2024-03-26
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT04248816 2023-02-14
Hepatocellular Carcinoma Surveillance in Cirrhotics
University of Pennsylvania
Phase NA Completed
NCT02224456 2022-02-14
Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis
GlaxoSmithKline
Phase 4 Completed
NCT03738332 2022-02-01
Low-Level Laser in Treatment of Head and Neck Lymphedema: A Pilot Study
University of Pennsylvania
Phase NA Completed
NCT01981850 2022-01-05
A Phase 2 Study of RO7490677 In Participants With Myelofibrosis
Hoffmann-La Roche
Phase 2 Completed
NCT01264705 2020-11-12
Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer
University of Texas Southwestern Medical Center
Phase 1/2 Completed
NCT01771991 2019-04-05
Sodermix
Sanford Health
Phase NA Completed
NCT00122135 2015-12-14
Aim3
VA Office of Research and Development
Phase NA Completed
NCT00583700 2013-01-29
Trental & Vitamin E for Radiation-Induced Fibrosis
University of Iowa
Phase 2 Completed